Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Predicting beta-interferon failure in relapsing-remitting multiple sclerosis.

K O'Rourke1, C Walsh, G Antonelli

  • 1Department of Neurology, St Vincent's University Hospital, Dublin, Ireland.

Multiple Sclerosis (Houndmills, Basingstoke, England)
|April 19, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Re: An exploratory study of bacterial contamination on communal mobile handheld devices in an animal referral hospital in the United Kingdom.

New Zealand veterinary journal·2026
Same author

Mechanical ventilation for young people with Duchenne muscular dystrophy: a factorial survey of the main influences on clinician decision-making.

European journal of pediatrics·2025
Same author

Molecular mobility of extraterrestrial ices: surface diffusion in astrochemistry and planetary science.

Physical chemistry chemical physics : PCCP·2025
Same author

The use of sequential multiple assignment randomized trials (SMARTs) in physical activity interventions: a systematic review.

BMC medical research methodology·2024
Same author

Micro to macro scale anatomical analysis of the human hippocampal arteries with synchrotron hierarchical phase-contrast tomography.

Surgical and radiologic anatomy : SRA·2024
Same author

The Causal Role of Vitamin D Deficiency in Worse Covid-19 Outcomes: Implications for Policy and Practice Development.

Irish medical journal·2023

Beta-interferon (IFNbeta) treatment significantly reduced disability accumulation in relapsing-remitting multiple sclerosis (RRMS) patients compared to controls. However, higher baseline disability and persistent relapses indicated a greater risk of future disability.

Area of Science:

  • Neurology
  • Immunology
  • Clinical Therapeutics

Background:

  • Beta-interferon (IFNbeta) treatment failure criteria for relapsing-remitting multiple sclerosis (RRMS) lack clinical validation.
  • Assessing IFNbeta's efficacy in preventing fixed disability accumulation is crucial for patient management.

Purpose of the Study:

  • To validate IFNbeta treatment failure criteria in RRMS patients.
  • To compare disability accumulation in IFNbeta-treated patients versus historical controls.
  • To identify predictors of fixed disability accumulation.

Main Methods:

  • Retrospective cohort study comparing 175 IFNbeta-treated RRMS patients with matched historical controls.
  • Analysis of disability accumulation over a median five-year follow-up.

Related Experiment Videos

  • Multivariate analysis of clinical and demographic variables, including relapse occurrence and Expanded Disability Status Scale (EDSS) scores.

    • Main Results:

    • IFNbeta treatment significantly reduced fixed disability accumulation compared to controls (P<0.0001).
    • 34% of treated patients accumulated fixed disability.
    • Relapse occurrence predicted disability accumulation (80% sensitivity, 43% specificity).
    • Higher baseline EDSS and failure to suppress relapses predicted increased disability accumulation (P=0.02 and P=0.004, respectively).

    Conclusions:

    • IFNbeta therapy is effective in reducing fixed disability accumulation in RRMS patients over five years.
    • Higher baseline EDSS scores and incomplete relapse suppression are significant risk factors for accumulating fixed disability.
    • Relapse-based criteria and baseline EDSS are valuable in predicting treatment failure.